动物模型市场规模、份额和成长分析（按动物类型、技术、应用、最终用户和地区）- 产业预测 2025-2032

2023 年全球动物模型市场规模价值为 28 亿美元，预计将从 2024 年的 30.3 亿美元成长到 2032 年的 56.4 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.1%。

动物模型市场对于研究癌症和心血管疾病等慢性疾病、寻求准确代表人体生理学的研究人员至关重要。该市场的成长是由复杂健康问题的不断增加和个人化医疗的需求所推动的。基因转殖小鼠等基因改造模型的进步使得人们能够详细研究基因功能和疾病机制。此外，以患者为来源的动物模型的兴起正在推动精准医疗的趋势。儘管存在道德考虑和替代技术等挑战，市场仍然蓬勃发展，并为药物开发和科学理解做出贡献。预计美国动物模型市场在未来的预测期内将保持持续的复合年增长率，显示未来具有很高的成长潜力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

动物模型市场规模（按动物类型和复合年增长率） (2025-2032)

• 市场概况
• 老鼠
• 老鼠
• 天竺鼠
• 兔子
• 仓鼠
• 其他的

动物模型市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• CRISPR
• 显微注射
• 胚胎干细胞注射

动物模型市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 研究与开发
• 生产
• 品管

动物模型市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 研究组织
• 教育机构
• 製药公司
• 合约研究组织

动物模型市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Charles River Laboratories（USA）
• The Jackson Laboratory（USA）
• Janvier Labs（France）
• Genoway（France）
• Ozgene（Australia）
• Hera Biolabs（UK）
• Crown Bioscience（USA）
• Inotiv（USA）
• Transgenic（Japan）
• JSR Life Sciences（Japan）
• Biocytogen（China）
• Harbour BioMed（China）
• Cyagen Biosciences（China）
• Horizon Discovery（UK）
• Cellectis（France）
• CRISPR Therapeutics（Switzerland）
• Editas Medicine（USA）
• Intellia Therapeutics（USA）

结论和建议

Global Animal Model Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.03 billion in 2024 to USD 5.64 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The animal model market is essential for researchers seeking accurate representations of human physiology to study chronic diseases, including cancer and cardiovascular disorders. Growth in this market is driven by the increasing incidence of complex health issues and the demand for personalized medicine. Advancements in genetically modified models, like transgenic mice, enable detailed investigations into gene functions and disease mechanisms. Additionally, the rise of patient-derived animal models supports the trend toward precision medicine. Despite challenges such as ethical considerations and alternative technologies, the market continues to thrive, contributing to drug development and scientific understanding. The US animal model market is expected to maintain a sustainable CAGR in the upcoming forecast period, indicating strong future growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Model Market Segments Analysis

Global Animal Model Market is segmented by Animal Type, Technology, Application, End User and region. Based on Animal Type, the market is segmented into Mice, Rat, Guinea Pigs, Rabbits, Hamsters and Others. Based on Technology, the market is segmented into CRISPR, Microinjection and Embryonic Stem Cell Injection. Based on Application, the market is segmented into Research and Development, Production and Quality Control. Based on End User, the market is segmented into Research Institutes, Educational Institutes, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Model Market

The Global Animal Model market is significantly driven by innovations in genomics and precision medicine, as there is a rising demand for animal models that can closely mimic individual patient characteristics and responses to therapies. Both researchers and pharmaceutical companies are actively employing these models to explore specific genetic variations and create targeted treatments. A notable example is the emergence of patient-derived xenograft (PDX) models, which involve implanting patient tumor samples into animals for efficacy testing, gaining traction in 2022. This approach enables the assessment of treatment effectiveness tailored to each patient, thereby fueling the need for advanced animal models in the realm of personalized medicine.

Restraints in the Global Animal Model Market

While the animal model market has experienced notable progress, ethical issues and concerns regarding animal welfare continue to act as significant barriers as of 2022. The employment of animals in research invites ethical dilemmas and fosters discussions about their humane treatment. Stricter animal welfare regulations and heightened public scrutiny, especially in regions with rigorous standards, have intensified the examination of animal model usage. These ethical considerations and regulatory frameworks not only hinder market growth but also stimulate efforts to innovate and adopt alternative technologies and methodologies that could potentially replace animal models in research, shaping the future of the industry.

Market Trends of the Global Animal Model Market

In 2023, the Global Animal Model market continues to embrace a significant trend towards humanized and translational models, reflecting a heightened commitment to enhancing the relevance of research to human health. This shift involves the integration of human cells, tissues, and genetic modifications into animal models, enabling more accurate mimicking of human physiology and disease mechanisms. Notably, advancements such as humanized mice with functional human immune systems facilitate deeper exploration of complex conditions like immune-related diseases and the efficacy of novel immunotherapies. This evolving focus underscores the industry's objective to improve predictive outcomes in drug development and disease research, positioning humanized models as pivotal in the quest for translational success.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Model Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Global Animal Model Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CRISPR
• Microinjection
• Embryonic Stem Cell Injection

Global Animal Model Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research and Development
• Production
• Quality Control

Global Animal Model Market Size by End User & CAGR (2025-2032)

• Market Overview
• Research Institutes
• Educational Institutes
• Pharmaceutical Companies
• Contract Research Organizations

Global Animal Model Market Size & CAGR (2025-2032)

• North America (Animal Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Animal Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genoway (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hera Biolabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotiv (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JSR Life Sciences (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harbour BioMed (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations